Short-Term Debt to Equity: seastarmedical.com (ICU)

SeaStar Medical Holding (ICU) develops innovative renal failure treatments for intensive care units, ensuring recurring sales of ancillary materials. The production of blood purification systems is outsourced to third-party contractors while the company retains all intellectual property rights. The share price retrospective on GURU.Markets, where the indicator stands at 0.03, underscores the importance of expansion into the US pediatric segment and strict control over logistics costs.

Investors view SeaStar Medical Holding (ICU) as a defensive asset due to stable demand for renal intensive care equipment. When analyzing the current short-term debt-to-equity level, one should evaluate the ratio of liabilities due within one year to equity to identify potential cash flow gaps. The trend of this metric determines whether borrowing serves as a growth tool or signals a liquidity deficit within this non-cyclical business.